Abaandou L and Shiloach J (2018) Knocking out ornithine decarboxylase antizyme 1 (OAZ1) improves Recombinant protein expression in the HEK293 cell line. Med Sci (Basel) 6(2):48. https://doi.org/10.3390/medsci6020048

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baris MM, Serinan E, Calisir M, Simsek K, Aktas S, Yilmaz O, Ozdemir SK., and Secil M (2020) Xenograft tumor volume measurement in nude mice: estimation of 3d ultrasound volume measurements based on manual caliper measurements. DokuzEyulUniversitesiSaglikBilimleri Enstitusu, 2020(2). https://doi.org/10.30621/JBACHS.2020.902

Cat AN, Briones AM (2017) Isolation of mature adipocytes from white adipose tissue and gene expression studies by real-time quantitative RT-PCR. Methods Mol Biol 1527:283–295. https://doi.org/10.1007/978-1-4939-6625-7_22

Article  CAS  PubMed  Google Scholar 

Cho YH, Ro EJ, Yoon JS, Mizutani T, Kang DW, Park JC, Kim I, Clevers T, Choi H, K.Y (2020) 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation. Nat Commun 11(1):5321. https://doi.org/10.1038/s41467-020-19173-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB (2019) Colorectal Cancer Lancet 394(10207):1467–1480. https://doi.org/10.1016/S0140-6736(19)32319-0

Article  PubMed  Google Scholar 

Di Desidero T, Orlandi P, Fioravanti A, Cremolini C, Loupakis F, Marmorino F, Antoniotti C, Masi G, Lonardi S, Bergamo F, Zagonel V, Falcone A, Bocci G (2018) Pharmacokinetic analysis of metronomic capecitabine in refractory metastatic colorectal cancer patients. Invest New Drugs 36(4):709–714. https://doi.org/10.1007/s10637-018-0579-8

Article  CAS  PubMed  Google Scholar 

Elhamamsy AR, Metge BJ, Alsheikh HA, Shevde LA, Samant RS (2022) Ribosome biogenesis: A central player in cancer metastasis and therapeutic resistance. Cancer Res 82(13):2344–2353. https://doi.org/10.1158/0008-5472.CAN-21-4087

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fares JE, El Tomb P, Khalil LE, Atwani RW, Moukadem HA, Awada A, Saghir E, N.S (2020) Metronomic chemotherapy for patients with metastatic breast cancer: review of effectiveness and potential use during pandemics. Cancer Treat Rev 89:102066. https://doi.org/10.1016/j.ctrv.2020.102066

Article  CAS  PubMed  Google Scholar 

Filippi R, Lombardi P, Depetris I, Fenocchio E, Quarà V, Chilà G, Aglietta M, Leone F (2018) Rationale for the use of metronomic chemotherapy in Gastrointestinal cancer. Expert Opin Pharmacother 19(13):1451–1463. https://doi.org/10.1080/14656566.2018.1512585

Article  CAS  PubMed  Google Scholar 

Fu W, Lin Y, Bai M, Yao J, Huang C, Gao L, Mi N, Ma H, Tian L, Yue P, Zhang Y, Zhang J, Ren Y, Ding L, Dai L, Leung JW, Yuan J, Zhang W, Meng W (2024) Beyond ribosomal function: RPS6 deficiency suppresses cholangiocarcinoma cell growth by disrupting alternative splicing. Acta Pharm Sinica B 14(9):3931–3948. https://doi.org/10.1016/j.apsb.2024.06.028

Article  CAS  Google Scholar 

Ge J, Karijolich J, Zhai Y, Zheng J, Yu YT (2017) 5-Fluorouracil treatment alters the efficiency of translational recoding. Genes (Basel) 8(11):295. https://doi.org/10.3390/genes8110295

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gmeiner WH, Okechukwu CC (2023) Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects. Cancer Drug Resist 6(2):257–272. https://doi.org/10.20517/cdr.2022.136

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gutiérrez LG, Hernández-Morales M, Núñez L, Villalobos C (2019) Inhibition of polyamine biosynthesis reverses Ca channel remodeling in colon Cancer cells. Cancers (Basel) 11(1):83. https://doi.org/10.3390/cancers11010083

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hata A, Seoane J, Lagna G, Montalvo E, Hemmati-Brivanlou A, andMassagué J (2000) OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell, 100(2):229 – 40. https://doi.org/10.1016/s0092-8674(00)81561-5

Hong XC, Liang QL, Chen M, Yang HX, Huang J, Yi SL, Wang ZW, Liang HY, Zhang DY, Huang ZY (2022) PRL-3 and MMP9 expression and Epithelial-Mesenchymal transition markers in Circulating tumor cells from patients with colorectal cancer: potential value in clinical practice. Front Oncol 12:878639. https://doi.org/10.3389/fonc.2022.878639

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang WY, Ho CL, Lee CC, Hsiao CW, Wu CC, Jao SW, Yang JF, Lo CH, Chen JH (2017) Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer. PLoS ONE 12(3):e0174280. https://doi.org/10.1371/journal.pone.0174280

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang CY, Fang YJ, Abulimiti A, Yang X, Li L, Liu KY, Zhang X, Feng XL, Chen YM, Zhang CX (2020) Dietary polyamines intake and risk of colorectal cancer: a case-control study. Nutrients 12(11):3575. https://doi.org/10.3390/nu12113575

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jang JS, Wang X, Vedell PT, Wen J, Zhang J, Ellison DW, Evans JM, Johnson SH, Yang P, Sukov WR, Oliveira AM, Vasmatzis G, Sun Z, Jen J, Yi ES (2016) Custom gene capture and next-generation sequencing to resolve discordant ALK status by FISH and IHC in lung adenocarcinoma. J Thorac Oncol 11(11):1891–1900. https://doi.org/10.1016/j.jtho.2016.06.001

Article  PubMed  PubMed Central  Google Scholar 

Jung YH, Lee WJ, Byeon JH, Lee IK, Han CW, Woo IS (2017) Metronomic chemotherapy with capecitabine for metastatic colorectal cancer in very elderly patients. Korean J Intern Med 32(5):926–929. https://doi.org/10.3904/kjim.2015.049

Article  PubMed  Google Scholar 

Kahana C (2016) Protein degradation, the main hub in the regulation of cellular polyamines. Biochem J 473(24):4551–4558. https://doi.org/10.1042/BCJ20160519C

Article  CAS  PubMed  Google Scholar 

Kaprio T, Rasila T, Hagström J, Mustonen H, Lankila P, Haglund C, Andersson LC (2019) Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancer. PLoS ONE 14(2):e0211564. https://doi.org/10.1371/journal.pone.0211564

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khatib AW, Selub SM, Uryvaey A, Baranseh J, Shai A (2023) Initiating treatment with low fluorouracil dose and titrating according to blood levels in patients treated with a 46-Hour continuous infusion. Chemotherapy 68(2):95–101. https://doi.org/10.1159/000526827

Article  CAS  PubMed  Google Scholar 

Kumar A, Sinha N, Bhardwaj A, Goel S (2022) Clinical risk assessment of chronic kidney disease patients using genetic programming. Comput Methods Biomech Biomed Engin 25(8):887–895. https://doi.org/10.1080/10255842.2021.1985476

Article  PubMed  Google Scholar 

Lalchandani UR, Sahai V, Hersberger K, Francis IR, Wasnik AP (2019) A radiologist’s guide to response evaluation criteria in solid tumors. Curr Probl Diagn Radiol 48(6):576–585. https://doi.org/10.1067/j.cpradiol.2018.07.016

Article  PubMed  Google Scholar 

Lee YR, An KY, Jeon J, Kim NK, Lee JW, Hong J, Chung BC (2020) Untargeted metabolomics and polyamine profiling in serum before and after surgery in colorectal cancer patients. Metabolites 10(12):487. https://doi.org/10.3390/metabo10120487

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liang QL, Wang BR, Li GH (2009) DcR3 and survivin are highly expressed in colorectal carcinoma and closely correlated to its clinicopathologic parameters. J Zhejiang Univ Sci B 10(9):675–682. https://doi.org/10.1631/jzus.B0920077

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mauri G, Sartore-Bianchi A, Russo AG, Marsoni S, Bardelli A, Siena S (2019) Early-onset colorectal cancer in young individuals. Mol Oncol 13(2):109–131. https://doi.org/10.1002/1878-0261.12417

Article  PubMed  Google Scholar 

McQuade RM, Stojanovska V, Bornstein JC, andNurgali K (2017) Colorectal cancer chemotherapy: the evolution of treatment and new approaches. Curr Med Chem 24(15):1537–1557. https://doi.org/10.2174/0929867324666170111152436